1129 related articles for article (PubMed ID: 20598579)
1. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
[TBL] [Abstract][Full Text] [Related]
2. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
3. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial thrombolysis for acute ischemic stroke in octogenarians.
Mono ML; Romagna L; Jung S; Arnold M; Galimanis A; Fischer U; Kohler A; Ballinari P; Brekenfeld C; Gralla J; Schroth G; Mattle HP; Nedeltchev K
Cerebrovasc Dis; 2012; 33(2):116-22. PubMed ID: 22179504
[TBL] [Abstract][Full Text] [Related]
5. Protocol adherence and safety of intravenous thrombolysis after telephone consultation with a stroke center.
Uchino K; Massaro L; Jovin TG; Hammer MD; Wechsler LR
J Stroke Cerebrovasc Dis; 2010; 19(6):417-23. PubMed ID: 21051004
[TBL] [Abstract][Full Text] [Related]
6. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
7. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
[TBL] [Abstract][Full Text] [Related]
8. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.
Shobha N; Buchan AM; Hill MD;
Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
10. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
Al-Khaled M; Matthis C; Eggers J
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
[TBL] [Abstract][Full Text] [Related]
11. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
12. Outcome of intravenous thrombolysis in stroke patients weighing over 100 kg.
Sarikaya H; Arnold M; Engelter ST; Lyrer PA; Mattle HP; Michel P; Odier C; Weder B; Siebel P; Mueller F; Ballinari P; Georgiadis D; Baumgartner RW
Cerebrovasc Dis; 2011; 32(3):201-6. PubMed ID: 21822011
[TBL] [Abstract][Full Text] [Related]
13. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
[TBL] [Abstract][Full Text] [Related]
14. Does dementia increase risk of thrombolysis?: a case-control study.
Alshekhlee A; Li CC; Chuang SY; Vora N; Edgell RC; Kitchener JM; Kale SP; Feen E; Piriyawat P; Callison RC; Cruz-Flores S
Neurology; 2011 May; 76(18):1575-80. PubMed ID: 21451151
[TBL] [Abstract][Full Text] [Related]
15. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
[TBL] [Abstract][Full Text] [Related]
16. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC
Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
[TBL] [Abstract][Full Text] [Related]
17. Drop of PT Quick percent value is associated with both symptomatic and asymptomatic intracranial hemorrhage in patients treated with rt-PA for acute ischemic stroke.
Alonso A; Dempfle CE; Szabo K; Zohsel K; Hennerici MG
Thromb Res; 2011 Jan; 127(1):65-6. PubMed ID: 20537372
[No Abstract] [Full Text] [Related]
18. Intravenous thrombolysis for acute cerebral ischaemia: comparison of outcomes between patients treated at working versus nonworking hours.
Bodenant M; Leys D; Debette S; Cordonnier C; Dumont F; Hénon H; Girot M; Lucas C; Devos D; Defebvre L; Deplanque D; Leclerc X; Bordet R
Cerebrovasc Dis; 2010; 30(2):148-56. PubMed ID: 20551630
[TBL] [Abstract][Full Text] [Related]
19. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).
Mori E; Minematsu K; Nakagawara J; Yamaguchi T;
J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):517-22. PubMed ID: 20719535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
